Fri, Sep-01-23, 06:34
|
|
Senior Member
Posts: 14,684
|
|
Plan: EpiPaleo/Primal/LowOx
Stats: 220/130/150
BF:
Progress: 129%
Location: USA
|
|
US Medicare negotiates for drugs, Pharma loses mind
But I've also heard these are off-patent and their profits will not dwindle to the size of their brains, despite their PR otherwise.
Quote:
These price negotiations are part of a program established by the Inflation Reduction Act last year, with the goal of making popular drugs more affordable to older and disabled Americans.
It gives the government, through Medicare, the authority to negotiate lower prices with pharmaceutical companies for select medications. Today, the Biden administration listed the first 10 drugs up for negotiation.
Popular blood thinners like Eliquis and Xarelto are on the, list as well as diabetes medications like Jardiance. Last year, just these 10 drugs cost Medicare recipients $3.4 billion out of pocket and cost the Medicare program $50 billion.
Medicare drug price negotiations could save government billions
|
My italics. I had caught from a news program that the target is for the biggest and most expensive drugs, which are denoted as: diabetes, cancer, autoimmune, and heart disease, as I recall. I remembered, because these are largely chronic diseases caused by poor diet.
The 10 drugs treat diseases common in Medicare Part D, such as blood clots, diabetes, heart disease and chronic kidney disease, officials said.
Medicare's first drug price negotiations will focus on insulin, blood thinners and more. The ten drugs are:
Eliquis
Jardiance
Xarelto
Januvia
Farxiga
Entresto
Enbrel
Imbruvica
Stelara
Fiasp; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill
Big Pharma and Big Junk Food aren't exactly the same companies, I know. But they certainly want to be.
|